Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22751
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Paz-Ares, L | - |
dc.contributor.author | Doebele, R C | - |
dc.contributor.author | Farago, A F | - |
dc.contributor.author | Liu, S V | - |
dc.contributor.author | Chawla, S P | - |
dc.contributor.author | Tosi, D | - |
dc.contributor.author | Blakely, C M | - |
dc.contributor.author | Krauss, J C | - |
dc.contributor.author | Sigal, D | - |
dc.contributor.author | Bazhenova, L | - |
dc.contributor.author | John, Thomas | - |
dc.contributor.author | Besse, B | - |
dc.contributor.author | Wolf, J | - |
dc.contributor.author | Seto, T | - |
dc.contributor.author | Chow-Maneval, E | - |
dc.contributor.author | Ye, C | - |
dc.contributor.author | Simmons, B | - |
dc.contributor.author | Demetri, G D | - |
dc.date.accessioned | 2020-03-10T22:06:20Z | - |
dc.date.available | 2020-03-10T22:06:20Z | - |
dc.date.issued | 2019-04 | - |
dc.identifier.citation | Annals of oncology : official journal of the European Society for Medical Oncology 2019; 30 Suppl 2: ii48-ii49 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/22751 | - |
dc.language.iso | eng | - |
dc.title | Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001. | - |
dc.type | Journal Article | - |
dc.identifier.journaltitle | Annals of oncology : official journal of the European Society for Medical Oncology | - |
dc.identifier.affiliation | Hospital 12 de Octubre, Madrid, Spain | - |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | University of Colorado, Aurora, CO, USA | - |
dc.identifier.affiliation | Massachusetts General Hospital, Boston, MA, USA | - |
dc.identifier.affiliation | Georgetown University, Washington, DC, USA | - |
dc.identifier.affiliation | Sarcoma Oncology Research Center, Santa Monica, CA, USA | - |
dc.identifier.affiliation | Medical Oncology Departement, Institut du Cancer de Montpellier Inserm U1194, Montpellier University, Montpellier, France | - |
dc.identifier.affiliation | University of California, San Francisco, CA, USA | - |
dc.identifier.affiliation | University of Michigan, Ann Arbor, MI, USA | - |
dc.identifier.affiliation | Scripps Clinic, La Jolla, CA, USA | - |
dc.identifier.affiliation | University of California, San Diego, CA, USA | - |
dc.identifier.affiliation | Gustave Roussy Cancer Campus, Villejuif, France | - |
dc.identifier.affiliation | University Hospital of Cologne, Cologne, Germany | - |
dc.identifier.affiliation | National Kyushu Cancer Center, Fukuoka, Japan | - |
dc.identifier.affiliation | Ignyta, Inc., San Diego, CA, USA | - |
dc.identifier.affiliation | Genentech, South San Francisco, CA, USA | - |
dc.identifier.affiliation | Dana-Farber Cancer Institute, Boston, MA, USA | - |
dc.identifier.doi | 10.1093/annonc/mdz063.011 | - |
dc.identifier.pubmedid | 32131246 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | John, Thomas | |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
crisitem.author.dept | Medical Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.